These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19622587)

  • 1. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
    Lurje G; Husain H; Power DG; Yang D; Groshen S; Pohl A; Zhang W; Ning Y; Manegold PC; El-Khoueiry A; Iqbal S; Tang LH; Shah MA; Lenz HJ
    Ann Oncol; 2010 Jan; 21(1):78-86. PubMed ID: 19622587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.
    Lurje G; Leers JM; Pohl A; Oezcelik A; Zhang W; Ayazi S; Winder T; Ning Y; Yang D; Klipfel NE; Chandrasoma P; Hagen JA; DeMeester SR; DeMeester TR; Lenz HJ
    Ann Surg; 2010 May; 251(5):857-64. PubMed ID: 20101173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
    Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
    Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
    Uzunoglu FG; Yavari N; Bohn BA; Nentwich MF; Reeh M; Pantel K; Perez D; Tsui TY; Bockhorn M; Mann O; Izbicki JR; Wikman H; Vashist YK
    Lung Cancer; 2013 Jul; 81(1):123-9. PubMed ID: 23548249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.
    Uzunoglu FG; Kolbe J; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; König AM; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
    Ann Oncol; 2013 May; 24(5):1282-90. PubMed ID: 23293110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
    Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
    Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer.
    Dan S; Bai L; Li-Jie W; Ting Z; Zhi-Yuan M
    Cancer Invest; 2013 Jul; 31(6):390-6. PubMed ID: 23641912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
    Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G
    Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma.
    Ozen A; Kocak Z; Sipahi T; Oz-Puyan F; Cakina S; Saynak M; Ibis C; Karagol H
    Med Oncol; 2013 Mar; 30(1):357. PubMed ID: 23275116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
    de Martino M; Haitel A; Schatzl G; Klatte T
    J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of IL-8-251 T > A yields prognostic information in patients with gastric carcinoma.
    Cai X; Hu W; Zhang B; Dai N; Xu R; Qiu H; Wang D; Li Z; Jiang W
    Biomarkers; 2013 Nov; 18(7):559-64. PubMed ID: 23980896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.
    Sunakawa Y; Cao S; Berger MD; Matsusaka S; Yang D; Zhang W; Ning Y; Parekh A; Stremitzer S; Mendez A; Okazaki S; Wakatsuki T; Azuma M; Shimada K; Watanabe M; Koizumi W; Wu AH; Lenz HJ
    Pharmacogenomics J; 2017 Jan; 17(1):36-41. PubMed ID: 26503819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.
    Huang ZH; Hua D; Li LH; Zhu JD
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1129-34. PubMed ID: 18357466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
    Winder T; Bohanes P; Zhang W; Yang D; Power DG; Ning Y; Gerger A; Wilson PM; Tang LH; Shah M; Lee AS; Lenz HJ
    Ann Oncol; 2011 Nov; 22(11):2431-2439. PubMed ID: 21382870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
    Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
    Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer.
    Kim JG; Sohn SK; Chae YS; Moon JH; Kim SN; Kang BW; Kim GC; Lee MH; Jeon SW; Chung HY; Yu W
    Jpn J Clin Oncol; 2009 Aug; 39(8):497-501. PubMed ID: 19509001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.
    Lurje G; Zhang W; Schultheis AM; Yang D; Groshen S; Hendifar AE; Husain H; Gordon MA; Nagashima F; Chang HM; Lenz HJ
    Ann Oncol; 2008 Oct; 19(10):1734-41. PubMed ID: 18550579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer.
    Sun B; Lin Y; Wang X; Lan F; Yu Y; Huang Q
    Clin Lab; 2016 Nov; 62(11):2099-2105. PubMed ID: 28164661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.